Patent: 10,238,719
✉ Email this page to a colleague
Summary for Patent: 10,238,719
| Title: | Compositions and kits for enzymatic debridement and methods of using the same |
| Abstract: | A debridement enzyme for necrotic tissue is described that is not dependent upon proteolytic enzymatic activity but instead utilizes the amylase family of enzymes. The amylases (α-, β-, γ-amylase) are noted for the cleavage of the α-glycosidic bonds of polysaccharides, yielding lower molecular weight carbohydrate/sugar fragments. It has now been found that α-amylase is effective in the debridement of devitalized tissue. |
| Inventor(s): | Joseph Charles Salamone, Kelly Xiaoyu Chen LEUNG, Ann Beal Salamone, Katelyn Elizabeth Reilly |
| Assignee: | Rochal Technologies LLC |
| Application Number: | US15/414,182 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,238,719
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Sanofi-aventis U.s. Llc | ADLYXIN | lixisenatide | Injection | 208471 | July 27, 2016 | 10,238,719 | 2037-01-24 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,238,719
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016057788 | ⤷ Get Started Free |
| United States of America | 9592280 | ⤷ Get Started Free |
| United States of America | 2017151314 | ⤷ Get Started Free |
| United States of America | 2016101165 | ⤷ Get Started Free |
| >Country | >Patent Number | >Estimated Expiration |
